Florida Cancer Affiliates Announces Collaboration with Sarah Cannon Research Institute, Expanding Access to Cutting-Edge Cancer Trials in the Florida Panhandle

January 14, 2026

Florida Cancer Affiliates, through its affiliation with The US Oncology Network, is now conducting community-based clinical trials by collaborating with Sarah Cannon Research Institute (SCRI), a global leader in oncology research that conducts community-based clinical trials. Offered through Florida Cancer Affiliates’ Panama City location, the collaboration expands access to innovative cancer treatments for patients across the Florida Panhandle.

SCRI has contributed to pivotal research that has helped to advance the majority of new cancer therapies approved by the FDA in the past decade. Through this collaboration, SCRI at Florida Cancer Affiliates will provide patients with greater access to groundbreaking clinical trials—bringing world-class research directly into the community.

“For years, patients in the Panhandle have had to travel hundreds of miles to access clinical trials,” said Christopher Haberman, MD, principal investigator and medical oncologist at FCA. “Now, through SCRI at Florida Cancer Affiliates, they can receive investigational therapies right here at home.”

The collaboration with SCRI offers numerous advantages for cancer patients:

• Greater treatment options for individualized care plans
• Access to cutting-edge therapies generally not otherwise available locally
• Advanced clinical trial matching using SCRI’s Genospace technology and personalized medicine team

The practice recently enrolled its first patient in a national Limited-Stage Small Cell Lung Cancer trial and is opening a major Non-Small Cell Lung Cancer study, with additional trials across multiple disease sites planned for 2026. To search all open trials at SCRI at Florida Cancer Affiliates, visit trials.scri.com and enter zip code 32405.

About Florida Cancer Affiliates

Florida Cancer Affiliates (FCA) is a community-based medical oncology and hematology practice with locations in the Florida Panhandle. Supported by The US Oncology Network, FCA delivers advanced, compassionate cancer care close to home.

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations, conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, it has conducted more than 850 first-in-human clinical trials and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at over 200 locations in more than 20 states across the U.S.

Media Contact

Jaai Deodhar, Sr. Clinical Research Coordinator

Florida Cancer Affiliates – Panama City

Direct: (850) 763-0036